Sun Pharmaceutical agrees to buy Organon & Co. for $11.75bn in enterprise value
MLex Summary: Mumbai-based Sun Pharmaceutical Industries Limited has agreed to acquire Jersey City, New Jersey-based Organon & Co. in an all-cash transaction with an enterprise value of $11.75 billion. Organon is...To view the full article, register now.
Already a subscriber? Click here to view full article